Clinical Trials Directory

Trials / Unknown

UnknownNCT02943356

Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction

Observational Study to Evaluate the Effect of Tadalafil 5mg Once Daily on Erectile Dysfunction and QOL in Andropause Patients With Erectile Dysfunction

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
Male
Age
35 Years
Healthy volunteers
Not accepted

Summary

Observational study to evaluate the effect of Tadalafil 5mg once daily on Erectile Dysfunction and QOL in Andropause patients with Erectile Dysfunction. Patients will be observed for 8weeks.

Conditions

Interventions

TypeNameDescription
DRUGTadalafilPatients will be treated with Tadalafil for 8 weeks

Timeline

Start date
2016-07-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-10-24
Last updated
2016-10-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02943356. Inclusion in this directory is not an endorsement.